Skye Bioscience, Common Stock Alpha and Beta Analysis

SKYE Stock  USD 2.85  0.01  0.35%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Skye Bioscience, Common. It also helps investors analyze the systematic and unsystematic risks associated with investing in Skye Bioscience, over a specified time horizon. Remember, high Skye Bioscience,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Skye Bioscience,'s market risk premium analysis include:
Beta
0.89
Alpha
(0.61)
Risk
5.25
Sharpe Ratio
(0.03)
Expected Return
(0.18)
Please note that although Skye Bioscience, alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Skye Bioscience, did 0.61  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Skye Bioscience, Common stock's relative risk over its benchmark. Skye Bioscience, Common has a beta of 0.89  . Skye Bioscience, returns are very sensitive to returns on the market. As the market goes up or down, Skye Bioscience, is expected to follow. As of December 20, 2024, Book Value Per Share is expected to decline to -0.32. In addition to that, Tangible Book Value Per Share is expected to decline to -0.32.

Enterprise Value

11.75 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Skye Bioscience, Backtesting, Skye Bioscience, Valuation, Skye Bioscience, Correlation, Skye Bioscience, Hype Analysis, Skye Bioscience, Volatility, Skye Bioscience, History and analyze Skye Bioscience, Performance.

Skye Bioscience, Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Skye Bioscience, market risk premium is the additional return an investor will receive from holding Skye Bioscience, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Skye Bioscience,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Skye Bioscience,'s performance over market.
α-0.61   β0.89

Skye Bioscience, expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Skye Bioscience,'s Buy-and-hold return. Our buy-and-hold chart shows how Skye Bioscience, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Skye Bioscience, Market Price Analysis

Market price analysis indicators help investors to evaluate how Skye Bioscience, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Skye Bioscience, shares will generate the highest return on investment. By understating and applying Skye Bioscience, stock market price indicators, traders can identify Skye Bioscience, position entry and exit signals to maximize returns.

Skye Bioscience, Return and Market Media

The median price of Skye Bioscience, for the period between Sat, Sep 21, 2024 and Fri, Dec 20, 2024 is 4.26 with a coefficient of variation of 17.53. The daily time series for the period is distributed with a sample standard deviation of 0.76, arithmetic mean of 4.33, and mean deviation of 0.64. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Acquisition by Jenkins Annalisa of 70000 shares of Skye Bioscience, at 5.15 subject to Rule 16b-3
10/28/2024
2
Acquisition by Dhillon Punit of 110000 shares of Skye Bioscience, at 0.0171 subject to Rule 16b-3
11/01/2024
3
Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights
11/07/2024
4
Skye Bioscience Surpasses 50 percent Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor
11/14/2024
5
Disposition of 307 shares by Grayson Paul A. of Skye Bioscience, at 5.55 subject to Rule 16b-3
11/15/2024
6
Disposition of 86244 shares by Grayson Paul A. of Skye Bioscience, at 4.99 subject to Rule 16b-3
11/18/2024
7
Skye Bioscience chief development officer sells shares worth 97,721
11/20/2024
8
British Design Firm Forecasts 2025 Color Trends
11/21/2024
9
Callous coward Finlay MacDonald jailed for life after murdering his brother-in-law
11/29/2024
10
Insider Trading
12/09/2024
11
Skye Bioscience to Present at J.P. Morgan Healthcare Conference
12/19/2024

About Skye Bioscience, Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Skye or other stocks. Alpha measures the amount that position in Skye Bioscience, Common has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 (projected)
Graham Number6.075.76
Receivables Turnover12.0712.68
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Skye Bioscience, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Skye Bioscience,'s short interest history, or implied volatility extrapolated from Skye Bioscience, options trading.

Build Portfolio with Skye Bioscience,

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Skye Bioscience, Common is a strong investment it is important to analyze Skye Bioscience,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Skye Bioscience,'s future performance. For an informed investment choice regarding Skye Stock, refer to the following important reports:
Skye Bioscience, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Skye Bioscience, technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Skye Bioscience, trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...